Clinical trials are vital for advancing medical research, developing new treatments, ensuring patient safety, and ultimately improving the quality of healthcare
Get to know our main studies
Help the body’s immune system fight cancer cells
The IMNN-001 protocol is the immunotherapy that can be combined with a standard chemotherapy drug, potentially achieving better clinical outcomes than traditional treatment for individuals battling ovarian cancer.
A new hope for ovarian clear cell carcinoma patients
Treatment options are needed for ovarian clear cell carcinoma patients, since traditional chemotherapy has a low response rate for ovarian clear cell carcinoma.
Learn moreGet to know early: Estimate the chances of developing cancer
The Ignite-TX study focuses on increasing genetic testing among families potentially carrying hereditary cancer syndromes. Learn more about this life-saving research.
Learn moreBoost the immune system to fight cancer cells
Immunotherapy for patients with advanced or recurrent ovarian cancer is a major innovation, uniquely offered in Houston at the MD Anderson and Leiden B Johnson General Hospitals. Get to know the TRACTION study.
Learn moreEnhance the quality of life of ovarian cancer patients
Minimally Invasive Surgery can offer potential benefits for women facing advanced ovarian cancer – that's what the LANCE study aims to show.
Learn more
Great health results come with great communication
Created to empower healthcare professionals and patients, Precare is a digital platform that provides real-time communication channels and digital resources. With a patient-centered approach, we aim to engage patients actively and address their concerns promptly by using cutting-edge technologies.